Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1993 Aug 7;307(6900):349–353. doi: 10.1136/bmj.307.6900.349

Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis.

R Stevenson 1, K Ranjadayalan 1, P Wilkinson 1, R Roberts 1, A D Timmis 1
PMCID: PMC1678213  PMID: 8374415

Abstract

OBJECTIVE--To record prognosis and determinants of outcome in patients with acute myocardial infarction since thrombolysis was introduced. DESIGN--Observational study. SETTING--London district general hospital. PATIENTS--608 consecutive patients admitted to the coronary care unit with acute myocardial infarction between 1 January 1988 and 31 December 1991. MAIN OUTCOME MEASURE--All cause mortality, non-fatal ischaemic events (myocardial infarction, unstable angina), and revascularisation. RESULTS--Of the 608 patients, 89 (14.6%) died in hospital. 507 [corrected] patients were followed up after discharge from hospital. Mortality (95% confidence interval) at 30 days, one year, and three years was 16.0% (13.4% to 19.2%), 21.7% (18.6% to 25.2%), and 29.4% (25.3% to 33.9%) respectively. Event free survival (survival without a non-fatal ischaemic event) was 80.4% (77.0% to 83.4%) at 30 days, 66.8% (62.8% to 70.5%) at one year, and 56.1% (51.3% to 60.6%) at three years. Survival in patients treated with thrombolysis was considerably higher than in those not given thrombolysis (three year survival: 76.7% v 54.3%), although the incidence of non-fatal ischaemic events was the same in the two groups. Multivariate determinants of six month survival were left ventricular failure, treatment with thrombolysis and aspirin, smoking history, bundle branch block, and age. For patients who survived six months, age was the only factor related to long term survival. CONCLUSIONS--Although patients treated by thrombolysis had a relatively good prognosis, long term mortality and the incidence of non-fatal recurrent ischaemic events remained high. Effective strategies for the identification and treatment of high risk patients need to be reassessed.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbash G. I., White H. D., Modan M., Van de Werf F. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. J Am Coll Cardiol. 1992 Jul;20(1):36–41. doi: 10.1016/0735-1097(92)90134-9. [DOI] [PubMed] [Google Scholar]
  2. Cleempoel H., Vainsel H., Dramaix M., Lenaers A., Contu E., Hoylaerts M., Demaret B., de Marneffe M., Vandenbossche J. L., Renard M. Limitations on the prognostic value of predischarge data after myocardial infarction. Br Heart J. 1988 Aug;60(2):98–103. doi: 10.1136/hrt.60.2.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Deckers J. W., Fioretti P., Brower R. W., Baardman T., Beelen A., Simoons M. L. Prediction of 1-year outcome after complicated and uncomplicated myocardial infarction: Bayesian analysis of predischarge exercise test results in 300 patients. Am Heart J. 1987 Jan;113(1):90–95. doi: 10.1016/0002-8703(87)90014-7. [DOI] [PubMed] [Google Scholar]
  4. Dubois C., Pierard L. A., Albert A., Smeets J. P., Demoulin J. C., Boland J., Kulbertus H. E. Short-term risk stratification at admission based on simple clinical data in acute myocardial infarction. Am J Cardiol. 1988 Feb 1;61(4):216–219. doi: 10.1016/0002-9149(88)90918-6. [DOI] [PubMed] [Google Scholar]
  5. Ellis S. G., Topol E. J., George B. S., Kereiakes D. J., Debowey D., Sigmon K. N., Pickel A., Lee K. L., Califf R. M. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation. 1989 Nov;80(5):1159–1165. doi: 10.1161/01.cir.80.5.1159. [DOI] [PubMed] [Google Scholar]
  6. Fabricius-Bjerre N., Munkvad M., Knudsen J. B. Subendocardial and transmural myocardial infarction: a five year survival study. Am J Med. 1979 Jun;66(6):986–990. doi: 10.1016/0002-9343(79)90454-6. [DOI] [PubMed] [Google Scholar]
  7. Gomez-Marin O., Folsom A. R., Kottke T. E., Wu S. C., Jacobs D. R., Jr, Gillum R. F., Edlavitch S. A., Blackburn H. Improvement in long-term survival among patients hospitalized with acute myocardial infarction, 1970 to 1980. The Minnesota Heart Survey. N Engl J Med. 1987 May 28;316(22):1353–1359. doi: 10.1056/NEJM198705283162201. [DOI] [PubMed] [Google Scholar]
  8. Harrison D. G., Ferguson D. W., Collins S. M., Skorton D. J., Ericksen E. E., Kioschos J. M., Marcus M. L., White C. W. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation. 1984 May;69(5):991–999. doi: 10.1161/01.cir.69.5.991. [DOI] [PubMed] [Google Scholar]
  9. Henning H., Gilpin E. A., Covell J. W., Swan E. A., O'Rourke R. A., Ross J., Jr Prognosis after acute myocardial infarction: a multivariate analysis of mortality and survival. Circulation. 1979 Jun;59(6):1124–1136. doi: 10.1161/01.cir.59.6.1124. [DOI] [PubMed] [Google Scholar]
  10. Krone R. J., Friedman E., Thanavaro S., Miller J. P., Kleiger R. E., Oliver G. C. Long-term prognosis after first Q-wave (transmural) or non-Q-wave (nontransmural) myocardial infarction: analysis of 593 patients. Am J Cardiol. 1983 Aug;52(3):234–239. doi: 10.1016/0002-9149(83)90114-5. [DOI] [PubMed] [Google Scholar]
  11. Martin C. A., Thompson P. L., Armstrong B. K., Hobbs M. S., de Klerk N. Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register. Circulation. 1983 Nov;68(5):961–969. doi: 10.1161/01.cir.68.5.961. [DOI] [PubMed] [Google Scholar]
  12. McGovern P. G., Folsom A. R., Sprafka J. M., Burke G. L., Doliszny K. M., Demirovic J., Naylor J. D., Blackburn H. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985. The Minnesota Heart Survey. Circulation. 1992 Jan;85(1):172–179. doi: 10.1161/01.cir.85.1.172. [DOI] [PubMed] [Google Scholar]
  13. Mueller H. S., Cohen L. S., Braunwald E., Forman S., Feit F., Ross A., Schweiger M., Cabin H., Davison R., Miller D. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation. 1992 Apr;85(4):1254–1264. doi: 10.1161/01.cir.85.4.1254. [DOI] [PubMed] [Google Scholar]
  14. Murray D. P., Salih M., Tan L. B., Murray R. G., Littler W. A. Prognostic stratification of patients after myocardial infarction. Br Heart J. 1987 Apr;57(4):313–318. doi: 10.1136/hrt.57.4.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Norris R. M., Barnaby P. F., Brandt P. W., Geary G. G., Whitlock R. M., Wild C. J., Barratt-Boyes B. G. Prognosis after recovery from first acute myocardial infarction: determinants of reinfarction and sudden death. Am J Cardiol. 1984 Feb 1;53(4):408–413. doi: 10.1016/0002-9149(84)90003-1. [DOI] [PubMed] [Google Scholar]
  16. Peters B. S., Bennett J. M., Jeffries D. J., Knox K., Kocsis A., Pinching A. J. Ineffectiveness of AL721 in HIV disease. Lancet. 1990 Mar 3;335(8688):545–546. doi: 10.1016/0140-6736(90)90782-z. [DOI] [PubMed] [Google Scholar]
  17. Pohjola S., Siltanen P., Romo M. Five-year survival of 728 patients after myocardial infarction. A community study. Br Heart J. 1980 Feb;43(2):176–183. doi: 10.1136/hrt.43.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rivers J. T., White H. D., Cross D. B., Williams B. F., Norris R. M. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. J Am Coll Cardiol. 1990 Aug;16(2):340–348. doi: 10.1016/0735-1097(90)90583-b. [DOI] [PubMed] [Google Scholar]
  19. Sanz G., Castañer A., Betriu A., Magriña J., Roig E., Coll S., Paré J. C., Navarro-López F. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med. 1982 May 6;306(18):1065–1070. doi: 10.1056/NEJM198205063061801. [DOI] [PubMed] [Google Scholar]
  20. Simoons M. L., Serruys P. W., vd Brand M., Bär F., de Zwaan C., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Vermeer F. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet. 1985 Sep 14;2(8455):578–582. doi: 10.1016/s0140-6736(85)90584-7. [DOI] [PubMed] [Google Scholar]
  21. Simoons M. L., Vos J., Tijssen J. G., Vermeer F., Verheugt F. W., Krauss X. H., Cats V. M. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. J Am Coll Cardiol. 1989 Dec;14(7):1609–1615. doi: 10.1016/0735-1097(89)90003-x. [DOI] [PubMed] [Google Scholar]
  22. White H. D., Norris R. M., Brown M. A., Brandt P. W., Whitlock R. M., Wild C. J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987 Jul;76(1):44–51. doi: 10.1161/01.cir.76.1.44. [DOI] [PubMed] [Google Scholar]
  23. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]
  24. Williams D. O., Borer J., Braunwald E., Chesebro J. H., Cohen L. S., Dalen J., Dodge H. T., Francis C. K., Knatterud G., Ludbrook P. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation. 1986 Feb;73(2):338–346. doi: 10.1161/01.cir.73.2.338. [DOI] [PubMed] [Google Scholar]
  25. Wolffenbuttel B. H., Verdouw P. D., Scheffer M. G., Bom H. P., Bijleveld R. E., Hugenholtz P. G. Significance of haemodynamic variables in coronary care unit for prediction of survival after acute myocardial infarction. Br Heart J. 1983 Sep;50(3):266–272. doi: 10.1136/hrt.50.3.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES